001     274431
005     20240229154934.0
024 7 _ |a 10.15252/embr.202357162
|2 doi
024 7 _ |a pmid:36951170
|2 pmid
024 7 _ |a 1469-221X
|2 ISSN
024 7 _ |a 1469-3178
|2 ISSN
024 7 _ |a altmetric:148188968
|2 altmetric
037 _ _ |a DKFZ-2023-00595
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Lou, Dan
|b 0
245 _ _ |a Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparedness.
260 _ _ |a Hoboken, NJ [u.a.]
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1687856710_19593
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:A260# / 2023 May 4;24(5):e57162
520 _ _ |a Throughout the SARS-CoV-2 pandemic, limited diagnostic capacities prevented sentinel testing, demonstrating the need for novel testing infrastructures. Here, we describe the setup of a cost-effective platform that can be employed in a high-throughput manner, which allows surveillance testing as an acute pandemic control and preparedness tool, exemplified by SARS-CoV-2 diagnostics in an academic environment. The strategy involves self-sampling based on gargling saline, pseudonymized sample handling, automated RNA extraction, and viral RNA detection using a semiquantitative multiplexed colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay with an analytical sensitivity comparable with RT-qPCR. We provide standard operating procedures and an integrated software solution for all workflows, including sample logistics, analysis by colorimetry or sequencing, and communication of results. We evaluated factors affecting the viral load and the stability of gargling samples as well as the diagnostic sensitivity of the RT-LAMP assay. In parallel, we estimated the economic costs of setting up and running the test station. We performed > 35,000 tests, with an average turnover time of < 6 h from sample arrival to result announcement. Altogether, our work provides a blueprint for fast, sensitive, scalable, cost- and labor-efficient RT-LAMP diagnostics, which is independent of potentially limiting clinical diagnostics supply chains.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a COVID-19 tests
|2 Other
650 _ 7 |a RT-LAMP
|2 Other
650 _ 7 |a corona tests
|2 Other
650 _ 7 |a pandemic preparedness
|2 Other
650 _ 7 |a surveillance testing
|2 Other
700 1 _ |a Meurer, Matthias
|b 1
700 1 _ |a Ovchinnikova, Svetlana
|b 2
700 1 _ |a Burk, Robin
|b 3
700 1 _ |a Denzler, Anna
|b 4
700 1 _ |a Herbst, Konrad
|b 5
700 1 _ |a Papaioannou, Ioannis A
|0 0000-0002-8055-4024
|b 6
700 1 _ |a Duan, Yuanqiang
|0 0000-0002-4644-9706
|b 7
700 1 _ |a Jacobs, Max L
|b 8
700 1 _ |a Witte, Victoria
|0 0000-0002-0372-6005
|b 9
700 1 _ |a Ürge, Daniel
|b 10
700 1 _ |a Kirrmaier, Daniel
|0 P:(DE-He78)64436015382a1ba9cb1a84ebdba44850
|b 11
|u dkfz
700 1 _ |a Krogemann, Michelle
|b 12
700 1 _ |a Gubicza, Krisztina
|0 P:(DE-He78)8edd070d4a53d61b6042b99a38d69435
|b 13
|u dkfz
700 1 _ |a Boerner, Kathleen
|0 0000-0001-7705-9375
|b 14
700 1 _ |a Bundschuh, Christian
|b 15
700 1 _ |a Weidner, Niklas M
|b 16
700 1 _ |a Merle, Uta
|b 17
700 1 _ |a Knorr, Britta
|b 18
700 1 _ |a Welker, Andreas
|b 19
700 1 _ |a Denkinger, Claudia M
|0 0000-0002-7216-7067
|b 20
700 1 _ |a Schnitzler, Paul
|b 21
700 1 _ |a Kräusslich, Hans-Georg
|b 22
700 1 _ |a Dao Thi, Viet Loan
|0 0000-0003-2293-3592
|b 23
700 1 _ |a De Allegri, Manuela
|0 0000-0002-8677-1337
|b 24
700 1 _ |a Nguyen, Hoa Thi
|0 0000-0001-9626-2934
|b 25
700 1 _ |a Deckert, Andreas
|0 0000-0003-0526-6249
|b 26
700 1 _ |a Anders, Simon
|0 0000-0003-4868-1805
|b 27
700 1 _ |a Knop, Michael
|0 P:(DE-He78)03ae15a30a7fa7191475148bf4e7f581
|b 28
|e Last author
|u dkfz
773 _ _ |a 10.15252/embr.202357162
|0 PERI:(DE-600)2025376-X
|n 5
|p e57162
|t EMBO reports
|v 24
|y 2023
|x 1469-221X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:274431
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)64436015382a1ba9cb1a84ebdba44850
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)8edd070d4a53d61b6042b99a38d69435
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)03ae15a30a7fa7191475148bf4e7f581
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO REP : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EMBO REP : 2022
|d 2023-10-24
920 2 _ |0 I:(DE-He78)A260-20160331
|k A260
|l A260 Zellmorphogenese und Signalübermittlung
|x 0
920 1 _ |0 I:(DE-He78)A260-20160331
|k A260
|l A260 Zellmorphogenese und Signalübermittlung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A260-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21